Skip to content

Omeros OMER Contract Royalty Asset Noncurrent

Contract Royalty Asset Noncurrent at other companies

indie Semiconductor, Inc. logo
indie Semiconductor, Inc.INDI
$3.95M-62.7%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$193.54M+2.8%
Ouster logo
OusterOUST
$281K
Ceva logo
CevaCEVA
$9.16M+8.3%
Bloom Energy logo
Bloom EnergyBE
$63.28M
Ceva logo
CevaCEVA
$2.58M

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept omer:ContractRoyaltyAssetNoncurrent.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's contract royalty asset noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's contract royalty asset noncurrent?
Omeros (OMER) reported contract royalty asset noncurrent of $93.72M in Q1 2026.
How has Omeros's contract royalty asset noncurrent changed year-over-year?
Omeros's contract royalty asset noncurrent decreased by 22.9% year-over-year, from $121.56M to $93.72M.
What is the long-term trend for Omeros's contract royalty asset noncurrent?
Over 4 years (2021 to 2025), Omeros's contract royalty asset noncurrent has grown at a -8.9% compound annual growth rate (CAGR), from $140.25M to $96.44M.
What does contract royalty asset noncurrent mean?
This represents the long-term portion of intangible assets arising from contractual royalty agreements that are expected to be realized beyond one year. It captures the long-term value of intellectual property monetization and future revenue potential from licensing arrangements. This metric is critical for evaluating the long-term valuation of a company's proprietary technology portfolio.